First OTC Continuous Blood Glucose Monitor Cleared for Marke

First OTC Continuous Blood Glucose Monitor Cleared for Marketing by FDA

Dexcom Stelo Glucose Biosensor System is intended for people aged 18 years and older who have T2D but do not take insulin

Related Keywords

United States , Americans , Jeff Shuren , Radiological Health , Drug Administration , Healthday News , Dexcom Stelo Glucose Biosensor System ,